secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001860742-25-000016
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q2 revenue $1.278B, GAAP loss narrows to $62M, raises FY2025 guide
--------------------------------------------------------------------------------

- Revenue $1.278B, +5% as reported (+3% constant currency); Vision Care +8%, Surgical +3%, Pharma flat.
- GAAP net loss $62M ($0.18 loss per share) vs $151M loss ($0.43) a year ago; adjusted net income $25M ($0.07 adjusted EPS).
- Adjusted EBITDA $191M vs $209M prior year; Adj EBITDA ex-IPR&D $192M vs $212M.
- Raised FY2025 guidance: revenue $5.05B-$5.15B (prior $5.0B-$5.1B), constant currency growth ~5-7%; Adj EBITDA ex-IPR&D $860M-$910M.
- Resumed full production of enVista IOLs following recall; dry eye portfolio reached ~$1B trailing revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074225000016/0001860742-25-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074225000016/blco-20250730.htm
  HTML page:      https://secwatch.observer/filing/0001860742-25-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer